BRKRP
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
NASDAQ · Healthcare · Medical - Devices · US
$439.45
+0.33%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.5B | 3.4B | 3.4B | 3.0B | 2.5B |
| Cost of Revenue | 1.9B | 1.9B | 1.7B | 1.5B | 1.2B |
| Gross Profit | 1.6B | 1.6B | 1.6B | 1.5B | 1.3B |
| Operating Expenses | |||||
| R&D Expense | 393.5M | 395.2M | 376.5M | 294.8M | 235.9M |
| SG&A Expense | 970.7M | 946.5M | 893.8M | 729.4M | 607.4M |
| General & Admin Expense | 489.7M | 946.5M | 893.8M | 730.0M | 609.8M |
| Selling & Marketing Expense | — | — | — | (600.0K) | (2.4M) |
| Other Expenses | 143.2M | — | 126.1M | 52.2M | 29.7M |
| Total Operating Expenses | 1.5B | 1.3B | 1.4B | 1.1B | 873.0M |
| Cost and Expenses | 3.4B | 3.2B | 3.1B | 2.5B | 2.1B |
| Operating Income (EBIT) | 126.5M | 236.0M | 253.1M | 436.9M | 432.7M |
| Non-Operating | |||||
| Interest Income | 4.9M | 14.8M | 9.3M | 7.5M | 2.8M |
| Interest Expense | 43.7M | 60.3M | 47.9M | 16.4M | 16.1M |
| Net Interest Income | (38.8M) | (45.5M) | (38.6M) | (8.9M) | (13.3M) |
| Other Non-Op Income/Expense | (154.6M) | (215.0M) | (47.9M) | 109.3M | (17.8M) |
| Non-Operating Income (excl Interest) | 108.9M | 153.7M | (1.7M) | (123.7M) | 2.7M |
| EBT (Pre-Tax Income) | (28.1M) | 21.0M | 205.2M | 546.2M | 414.9M |
| Income Tax Expense | 40.4M | 29.3M | 91.4M | 117.7M | 116.4M |
| Bottom Line | |||||
| Net Income | (71.2M) | (8.6M) | 113.1M | 427.2M | 296.6M |
| Earnings from Cont. Ops | (68.5M) | (8.3M) | 113.8M | 428.5M | 298.5M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (106.9M) | (22.5M) | 113.1M | 427.2M | 296.6M |
| Per Share | |||||
| Basic EPS | ($0.70) | ($0.15) | $0.76 | $2.92 | $2.00 |
| Diluted EPS | ($0.70) | ($0.15) | $0.76 | $2.90 | $1.99 |
| Revenue Per Share | $22.99 | $22.64 | $22.59 | $20.25 | $17.03 |
| Shares | |||||
| Basic Shares Outstanding | 152.2M | 151.8M | 149.0M | 146.4M | 148.6M |
| Diluted Shares Outstanding | 152.2M | 151.8M | 149.5M | 147.2M | 149.4M |
| Profitability Metrics | |||||
| EBITDA | 247.7M | 302.6M | 438.6M | 675.5M | 518.7M |
| D&A | 230.1M | 220.3M | 183.8M | 114.9M | 88.7M |
| EBIT | 17.6M | 82.3M | 254.8M | 560.6M | 430.0M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026